Lopez sorry about the dissapointing announcement but can you provide a link to that research report?
In my opinion the announcement from The FDA was a bit vague which is unfair to current QRX investors.
Normally if more clinical studies are required by the FDA they will say so in the complete response letter .
Until more information is released in August the outlook for this stock will be uncertain.